Skip to main content
. 2021 Apr 9;30(9):2633–2647. doi: 10.1007/s11136-021-02833-1

Table 3.

Observed PROM scores, number of responders, and standardised response means by trial-arm and time-points

Measure ti Intervention (I), N = 241 Control (C), N = 120
Time-point (ti) Dif. time-points, tit0 Dif. time-points, titi-1 Time-point (ti) Dif. time-points, tit0
N (%) Mean (SD) N (%) Mean (SD) SRM N (%) Mean (SD) SRM N (%) Mean (SD) N (%) Mean (SD) SRM
PHQ-9 t0 241 (100) 14.41 (4.94) 120 (100) 14.18 (5.12)
t1 198 (82) 9.28 (5.94) 198 (82) − 5.21 (5.23) − 0.997 198 (82) − 5.21 (5.23) − 0.997 91 (76) 11.58 (5.68) 91 (76) − 2.28 (5.13) − 0.444
t2 186 (77) 8.17 (5.70) 186 (77) − 6.34 (5.43) − 1.168 177 (73) − 0.92 (4.26) − 0.216
t3 182 (76) 7.17 (5.83) 182 (76) − 7.12 (5.90) − 1.206 169 (70) − 0.82 (5.20) − 0.157
t4 177 (73) 6.81 (5.71) 177 (73) − 7.49 (5.94) − 1.261 167 (69) − 0.42 (4.88) − 0.086
t5 173 (72) 6.79 (5.54) 173 (72) − 7.56 (6.38) − 1.184 161 (67) − 0.10 (4.72) − 0.021
GAD-7 t0 241 (100) 12.66 (4.69) 120 (100) 12.54 (4.18)
t1 198 (82) 8.20 (5.31) 198 (82) − 4.50 (5.17) − 0.870 198 (82) − 4.50 (5.17) − 0.870 91 (76) 10.79 (5.12) 91 (76) − 1.63 (4.71) − 0.345
t2 186 (77) 7.38 (5.32) 186 (77) − 5.20 (5.37) − 0.968 177 (73) − 0.58 (4.04) − 0.144
t3 182 (76) 6.93 (5.52) 182 (76) − 5.48 (5.98) − 0.916 169 (70) − 0.28 (4.85) − 0.057
t4 176 (73) 6.48 (5.14) 176 (73) − 5.95 (5.87) − 1.013 166 (69) − 0.35 (4.60) − 0.076
t5 173 (72) 6.08 (4.81) 173 (72) − 6.56 (5.87) − 1.116 160 (66) − 0.65 (4.35) − 0.150
EQ-5D-5L t0 238 (99) 0.735 (0.152) 117 (98) 0.722 (0.182)
VSE t1 198 (82) 0.794 (0.147) 196 (81) 0.058 (0.133) 0.435 196 (81) 0.058 (0.133) 0.435 91 (76) 0.756 (0.181) 89 (74) 0.029 (0.138) 0.212
t2 186 (77) 0.816 (0.149) 184 (76) 0.078 (0.143) 0.547 177 (73) 0.020 (0.106) 0.187
t3 182 (76) 0.830 (0.171) 180 (75) 0.092 (0.168) 0.544 169 (70) 0.013 (0.141) 0.095
t4 176 (73) 0.837 (0.170) 174 (72) 0.096 (0.151) 0.631 166 (69) 0.002 (0.132) 0.019
t5 172 (71) 0.814 (0.172) 170 (71) 0.075 (0.167) 0.451 159 (66) − 0.007 (0.159) − 0.044
EQ-5D-5L t0 238 (99) 0.656 (0.193) 117 (98) 0.645 (0.218)
cross-walk t1 198 (82) 0.723 (0.182) 196 (81) 0.065 (0.178) 0.366 196 (81) 0.065 (0.178) 0.366 91 (76) 0.676 (0.231) 89 (74) 0.020 (0.172) 0.118
t2 186 (77) 0.753 (0.180) 184 (76) 0.090 (0.182) 0.496 177 (73) 0.023 (0.136) 0.171
t3 182 (76) 0.767 (0.212) 180 (75) 0.105 (0.217) 0.483 169 (70) 0.019 (0.178) 0.104
t4 176 (73) 0.779 (0.204) 174 (72) 0.112 (0.196) 0.573 166 (69) 0.007 (0.165) 0.040
t5 172 (71) 0.751 (0.201) 170 (71) 0.092 (0.215) 0.430 159 (66) − 0.009 (0.193) − 0.046
ReQoL-UI t0 237 (98) 0.788 (0.123) 116 (97) 0.757 (0.171)
t1 198 (82) 0.810 (0.140) 195 (81) 0.020 (0.141) 0.138 195 (81) 0.020 (0.141) 0.138 91 (76) 0.793 (0.163) 88 (73) 0.025 (0.139) 0.181
t2 186 (77) 0.836 (0.151) 183 (76) 0.045 (0.152) 0.295 177 (73) 0.022 (0.139) 0.162
t3 182 (76) 0.840 (0.144) 179 (74) 0.050 (0.166) 0.303 169 (70) 0.002 (0.145) 0.015
t4 176 (73) 0.863 (0.124) 173 (72) 0.070 (0.117) 0.599 166 (69) 0.019 (0.142) 0.131
t5 172 (71) 0.850 (0.135) 169 (70) 0.065 (0.138) 0.471 159 (66) − 0.006 (0.127) − 0.049
ReQoL-10 t0 237 (98) 18.52 (6.24) 116 (97) 18.76 (6.75)
t1 198 (82) 21.00 (6.85) 195 (81) 2.20 (6.17) 0.357 195 (81) 2.20 (6.17) 0.357 91 (76) 20.25 (6.40) 88 (73) 0.93 (6.17) 0.151
t2 186 (77) 24.10 (7.36) 183 (76) 5.37 (7.43) 0.723 177 (73) 3.04 (6.46) 0.471
t3 182 (76) 24.59 (7.90) 179 (74) 5.79 (7.95) 0.728 169 (70) 0.27 (7.52) 0.036
t4 176 (73) 25.49 (8.20) 173 (72) 6.66 (7.71) 0.863 166 (69) 0.92 (6.88) 0.134
t5 172 (71) 24.54 (8.31) 169 (70) 6.00 (7.50) 0.801 159 (66) − 0.66 (7.35) − 0.090
EQ-5D-5L t0 238 (99) 3.27 (0.83) 117 (98) 3.23 (0.82)
depression t1 198 (82) 2.64 (0.94) 196 (81) − 0.62 (0.95) − 0.649 196 (81) − 0.62 (0.95) − 0.649 91 (76) 2.91 (1.01) 89 (74) − 0.29 (0.87) − 0.336
/anxiety t2 186 (77) 2.44 (0.87) 184 (76) − 0.78 (0.99) − 0.784 177 (73) − 0.16 (0.84) − 0.195
item t3 182 (76) 2.30 (0.96) 180 (75) − 0.96 (1.08) − 0.883 169 (70) − 0.15 (0.97) − 0.159
t4 176 (73) 2.23 (0.99) 174 (72) − 1.02 (1.06) − 0.958 166 (69) − 0.08 (0.91) − 0.086
t5 172 (71) 2.31 (0.98) 170 (71) − 0.95 (1.06) − 0.897 159 (66) 0.04 (0.90) 0.049

t = time point, whereby: t0 = baseline; t1 = 8 weeks; t2 = 3 months; t3 = 6 months; t4 = 9 months; t5 = 12 months

N(%) states the number of people who completed the measure at the specific time-point, or at two given time-points e.g. relative to t0 (baseline) or ti (whereby i is any time-point denoted as 1–5)

Cohen’s SRM cut-off: < 0.2, trivial; 0.2 < 0.5, small; 0.5 < 0.8, medium; ≥ 0.8, large; an SRM of > 1 means the change in score between time-points is larger than one standard deviation

EQ-5D-5L EQ-5D Five Level version, GAD-7 generalised anxiety disorder-7, N number of people, ReQoL-UI(-10) Recovering Quality of Life—Utility Index (10 item), PHQ-9 Patient Health Questionnaire-9, SD standard deviation, SRM standardised response mean